Code No. | W013-3 | |
Anti-EFEMP1 (Fibulin-3) (Human) mAb | ||
Size | 100 µL (1 mg/mL) | |
Availability (in Japan) | 10 or more
(In Japan at 17:33, Apr 26, 2024 in JST) |
|
Clonality | Monoclonal | |
Clone | 2F9A1 | |
Isotype (Immunized Animal) |
Mouse IgG2aκ | |
Applications | FCM 1-10 µg/mL |
|
Immunogen (Antigen) |
Human EFEMP1 (Fibulin-3) expressed Ba/F3 transfectants generated from SST-REX (signalsequence trap by retrovirus-mediated expression screening). | |
Reactivity [Gene ID] | Human[2202] |
|
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | FBLN3, FBNL, DHRD, DRAD, FBNL, MLVT, MTLV, S1-5, FIBL-3 | |
Background | EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), also known as fibulin-3, belongs to the fibulin family of extracellular matrix glycoproteins, and shares a common structure that includes multiple calcium-binding EGF domains and a carboxyl-terminal fibulin domain. EFEMP1 plays a role in cell adhesion and migration, and is expressed in various cancer types. | |
Related products | MTG-001 Clear Back (Human Fc receptor blocking reagent) M076-3 Mouse IgG2a (isotype control) |
|
Product category | Research area:Cancer | |
Data | ||
References |
|